Introduction
Autophagy and apoptosis represent two mechanisms that can ultimately lead to cellular self-eradication. Although apoptosis exclusively eliminates cells, autophagy itself can have either a beneficial or detrimental cellular effect depending on the cellular context. It has been suggested that the net outcome of autophagy depends on multiple other events and processes. [1] [2] [3] [4] [5] [6] [7] Although evidence in mammals suggests some molecular coupling between autophagy and apoptosis, the exact molecular connection remains unclear.
Organelles and other cellular constituents including lipids, RNA, and proteins can undergo catabolism via macroautophagy, subsequently referred to herein as "autophagy".
Autophagy involves the sequestration of bulk cytoplasmic regions into double-membrane vacuoles that fuse their contents with late endosomal and lysosmal compartments for degradation. 4, 6, [8] [9] [10] [11] [12] [13] In addition, there are two other specialized forms of autophagy including chaperone-mediated autophagy (CMA) and microautophagy. CMA involves the selective targeting of proteins containing a KFERQ-like peptide motif to lysosomes for degradation. 6, 8, [13] [14] [15] [16] Microautophagy involves the pinocytosis of small quantities of cytosol directly by lysosomes. 6, 13, 17 If a cell under energetic stress cannot restore energy balance it will eventually die.
Cell death can be divided into two main mechanisms: apoptosis or necrosis. Apoptosis is a well-characterized programmed cell death event. The hallmarks of apoptosis include caspase activation, cellular shrinkage, pyknosis, and karyorrhexis. Recent evidence suggests a third type of cell death, autophagic cell death (ACD). 3-6, 18, 19 However, whether apoptosis and ACD are indeed uncoupled events or if autophagic failure leads to apoptosis remain unclear.
AMP-activated protein kinase (AMPK) is a serine-theronine kinase involved in sensing energy status in the cell and regulating metabolism. The heterotrimeric protein complex contains a catalytic subunit α and two regulatory subunits, β and γ respectively. [20] [21] [22] [23] [24] Cellular stressors including energetic stress, which lowers ATP levels, lead to activation of AMPK activity. In response, activated AMPK then turns on ATPgenerating pathways while inhibiting ATP-consuming pathways in order to increase ATP to AMP ratios. [20] [21] [22] [23] [24] AMPK is highly conserved with orthologues expressed in plants, yeast, Drosophila, Caenorhabditis (C.) elegans, vertebrates and mammals. 21, 23, 25, 26 The first mutations in an AMPK complex gene were identified as mutations in Snf1 (sucrose non-fermenting) protein kinase, the Saccharomyces cerevisiae orthologue of AMPKα. 21, [25] [26] [27] [28] In yeast, SNF1 has a role in fully inducing autophagy. 29 However, mammalian studies demonstrate conflicting roles for AMPK in autophagy. There have been several studies indicating that AMPK is an inducer of autophagy, [30] [31] [32] while there is evidence in hepatocytes that AMPK is an inhibitor of autophagy. 33, 34 In addition, many studies of AMPK and autophagy rely strictly on pharmacological agents, which may have off-target effects to activate or inhibit AMPK. Indeed, numerous studies demonstrating AICAR dependent but AMPK independent phenotypes exist. [35] [36] [37] [38] [39] In order to investigate the role of AMPK in autophagy and apoptosis without the use of pharmacological activators or inhibitors of AMPK, we took a genetic-based approach. We derived mouse embryonic fibroblasts (MEFs) lacking AMPK activity from genetically engineered mice to study them within an energy deprivation paradigm. Our results indicate that constitutive genetic loss of AMPK function in MEFs under low glucose lead to an increased basal rate of autophagy under serum-rich conditions. Further, due to elevated autophagy basally, genetically null AMPK cells are less equipped to survive stress exerted by further nutrient deprivation and undergo apoptosis.
Results

hours serum deprivation leads to apoptotic cell death in AMPKα -/-(null)
MEFs. Typical immortalized MEF cells are able to survive serum-free conditions for a brief period of time typically at least 24 hours. Serum deprivation ("starvation") can be used as a paradigm that more subtly mimics nutrient deprivation and is often followed with serum re-introduction to examine growth factor mediated signaling events.
However, in this study with low glucose we observed that serum deprivation itself quickly lead to cell death for cells simultaneously lacking both catalytic AMPK subunits, Figure 1A -C). Therefore our study focuses on low glucose effects on cell survival unless otherwise stated.
Total AMPKα1/α2 protein levels detected with two independent AMPK antibodies demonstrated significant reduction in AMPK -/-MEFs as expected ( Figure 1E ).
In addition, phosphorylated Acetyl-CoA Carboxylase (ACC) at Serine 79, a target site for AMPK activity, was also diminished ( Figure 1E ). However, it was not eliminated as other kinases, including PKA, have also been demonstrated to phosphorylate ACC.
To further confirm the cell death observed in AMPK -/-MEFs corresponded to an apoptotic event, we performed western blot analyses on these samples using wellestablished apoptotic markers, activated PARP and cleaved caspase 3. As expected for surviving cells, AMPK +/+ and AMPK -/-MEFs under serum-rich conditions did not display significant cleavage of caspase 3 or PARP (poly ADP ribose polymerase) ( Figure   1D ). However, after 20 hours of serum deprivation a significant increase in caspase 3 Figure 4A ). Upon addition of 3-MA, the increase in LC3-II was largely blunted and showed no increase at the later time points (12-20 hours) ( Figure 4B ). Additionally, the AMPK -/-cells exhibited much more apoptosis, suggestive of their increased reliance on autophagy under nutrient-rich conditions ( Figure 5B ). However, we do note that although 3-MA is widely used to inhibit autophagy, targets of 3-MA at 7mM may also include additional pathways such as the Akt survival pathway. Therefore, we do not rule out the possibility of off-target pathways that may play a part in the observed cell death. Therefore we decided to verify the 3-MA observation by knocking down an essential autophagy gene, ATG7, via a shRNA expressing plasmid under low glucose no serum conditions for 20 hours. However, we did not observe increased cell death as with the 3-MA treatment ( Figure 5C ). [40] [41] [42] 46 In most cases by ultimately affecting mTOR possibly through PTEN or the TSC1/2 complex.
3-Methyladenine inhibition of autophagy in both AMPK
p53 phosphorylation, specifically at serine 15 (ser15) is induced during glucose starvation suggesting a role of p53 coupling cellular energy and metabolism with cell growth. 43 Additionally, another study found that ultraviolet (UV) and hydrogen peroxide stress activated AMPK and p53 phosphorylation at ser15 to mediate stress induced apoptosis 47 . Therefore we wanted to determine whether p53 phosophorylation is induced 
Discussion
Autophagy can be induced during pathogenic invasion, starvation conditions, or stress as a means of maintaining homeostasis and viability. Altered regulation of autophagy -either as disease causing or disease treating -has received interest in many therapeutic areas including cancer, heart disease, neurodegeneration, lysosmal storage disease, and infectious disease. Further in vivo studies utilizing AMPKα knockouts, especially in hepatocytes, would further elucidate AMPK's role in autophagy.
Materials and Methods
Plasmids, reagents, and antibodies. The following plasmids, reagents, and antibodies were used in the study: pLC3-venus was a kind gift from Dr. Fan Wang 
